Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:14:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-06T20:58:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, as well as the introduction of cabozantinib as a relevant drug. However, several key pieces of information related to Ewing sarcoma and other related topics have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:29:15.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.1%
    Check dated 2025-08-23T14:07:51.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.16.12, replacing the previous version v2.16.11. The phrasing regarding the last update has been clarified from 'Estimated' to a definitive statement.
    Difference
    0.1%
    Check dated 2025-08-16T11:46:04.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has updated its versioning and date information, reflecting a new revision and the removal of outdated dates.
    Difference
    0.4%
    Check dated 2025-08-09T07:12:59.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.